Optimized Assessment of qPCR-Based Vector Copy Numbers as a Safety Parameter for GMP-Grade CAR T Cells and Monitoring of Frequency in Patients
Open accessAbstract
Chimeric antigen receptor (CAR) T cells are considered genetically modified organisms (GMOs) and constitute gene therapy medicinal products. Thus, CAR T cell manufacturing for clinical application is strictly regulated. Appropriate methods to assess vector copy numbers (VCNs) in CAR T cell products and monitoring of CAR T cell frequencies in patients are required. Quantitative polymerase chain reaction (qPCR) is the preferred method for VCN assessment. However, no standardized procedure with high reproducibility has been described yet. Here, we report on a single copy gene (SCG)-based duplex (DP)-qPCR assay (SCG-DP-PCR) to determine VCN in CAR T cell products. SCG-DP-PCR was validated and compared to the absolute standard curve method (ACM) within the framework of a clinical trial treating patients with good manufacturing practice (GMP)-grade CAR T cells at the University Hospital Heidelberg. Methodologically, SCG-DP-PCR displayed technical advantages over ACM and minimized mathematical analysis. SCG-DP-PCR, as a highly reproducible approach, can be used for clinical follow-up of patients treated with CAR T cells or other GMOs and might replace established methods for VCN quantification. This work will enable clinicians to assess VCN, as well as CAR T cell frequencies, in patients as a basis for decisions on subsequent therapies, including repeated CAR T cell administration.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
An excessive number of vector copies can lead to CAR overexpression, increasing toxicity risks.
“Safety: an excessive number of vector copies can lead to CAR overexpression, increasing toxicity risks.”
From Harmonisation of quality control tests for academic production of CAR-T cells: a position paper from the WP-bioproduction of the UNITC consortium (2025) · cites this paper as [31]
The Introduction (page not provided) says vector copy numbers must be assessed before CAR T-cell administration to warrant safety, and the Discussion (page not provided) calls their evaluation mandatory biosafety testing. Neither passage says excessive copies cause CAR overexpression or increase toxicity, so the proposed mechanism is unsupported. (LLM, conf=0.83)
Experimental — accuracy not yet measuredA high vector copy number raises the risk of insertional mutagenesis, where the vector integrates into genomic regions that could activate proto-oncogenes or disable tumor suppressor genes.
“Additionally, a high copy number raises the risk of insertional mutagenesis, where the vector integrates into genomic regions that could activate proto-oncogenes or disable tumor suppressor genes [28–31].”
From Harmonisation of quality control tests for academic production of CAR-T cells: a position paper from the WP-bioproduction of the UNITC consortium (2025) · cites this paper as [31]
The Discussion states that viral vectors integrate into the target-cell genome and that assessing integrated vector copy numbers is mandatory for biosafety. The Introduction also describes copy-number assessment as a safety measure. Neither passage says that a high copy number increases insertional-mutagenesis risk or describes activation of proto-oncogenes or disabling of tumor-suppressor genes. (LLM, conf=0.82)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860 · see citing works
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Neelapu, S. S., Locke, F. L., Bartlett, N. L., Lekakis, L. J., Miklos, D. B., Jacobson, C. A., Braunschweig, I., Oluwole, O. O., Siddiqi, T., Lin, Y., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707447 · Cited by 6,030 · see citing works
Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia
Maude, S. L., Laetsch, T. W., Buechner, J., Rives, S., Boyer, M., Bittencourt, H., Bader, P., Verneris, M. R., Stefanski, H. E., Myers, G. D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709866 · Cited by 5,735 · see citing works
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407222 · Cited by 5,413 · cited 1× · see citing works
“Additionally, response to CAR T cell treatment is associated with expansion,(6) as well as persistence of CAR T cells in treated patients.(10,13) Therefore, the assessment of CAR T cell levels in patients at different time points after CAR T cell administration is crucial for deciding on further patient therapies.”
BackgroundMutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837 · see citing works
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
Park, J. H., Rivière, I., Gonen, M., Wang, X., Sénéchal, B., Curran, K. J., Sauter, C., Wang, Y., Santomasso, B., Mead, E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709919 · Cited by 2,688 · see citing works
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Davila, M. L., Rivière, I., Wang, X., Bartido, S. M., Park, J. H., Curran, K. J., Chung, S. S., Stefanski, J., Bórquez-Ojeda, O., Olszewska, M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008226 · Cited by 2,484 · see citing works
Chimeric Antigen Receptor Therapy
June, C. H., & Sadelain, M. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1706169 · Cited by 2,355 · see citing works
Porter, D. L., Hwang, W.-T., Frey, N. V., Lacey, S. F., Shaw, P. A., Loren, A. W., Bagg, A., Marcucci, K. T., Shen, A., Gonzalez, V., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac5415 · Cited by 1,729 · see citing works
Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
Schuster, S., Svoboda, J., Chong, E., Nasta, S., Mato, A., Anak, Ö., Brogdon, J., Pruteanu-Malinici, I., Bhoj, V. G., Landsburg, D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1708566 · Cited by 1,599 · see citing works
Gardner, R., Finney, O. C., Annesley, C., Brakke, H., Summers, C. N., Leger, K. J., Bleakley, M., Brown, C., Mgebroff, S., Kelly‐Spratt, K. S., et al. (2017) · Blood · doi:10.1182/blood-2017-02-769208 · Cited by 1,124 · see citing works
Turtle, C. J., Hanafi, L.-A., Berger, C., Hudecek, M., Pender, B., Robinson, E., Hawkins, R., Chaney, C., Cherian, S., Chen, X., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf8621 · Cited by 1,016 · see citing works
Turtle, C. J., Hay, K. A., Hanafi, L., Li, D., Cherian, S., Chen, X., Wood, B. L., Lozanski, A., Byrd, J. C., Heimfeld, S., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.72.8519 · Cited by 660 · see citing works
Till, B. G., Jensen, M. C., Wang, J., Qian, X., Gopal, A. K., Maloney, D. G., Lindgren, C. G., Lin, Y., Pagel, J. M., Budde, L. E., et al. (2012) · Blood · doi:10.1182/blood-2011-10-387969 · Cited by 531 · see citing works
Hollyman, D., Stefanski, J., Przybylowski, M., Bartido, S. M., Bórquez-Ojeda, O., Taylor, C., Yeh, R., Capacio, V., Olszewska, M., Hosey, J., et al. (2009) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318194a6e8 · Cited by 316 · see citing works
Kochenderfer, J. N., Somerville, R. P. T., Lu, T., Yang, J. C.-H., Sherry, R. M., Feldman, S. A., McIntyre, L. S., Bot, A. I., Rossi, J. M., Lam, N., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.07.004 · Cited by 284 · see citing works
Singh, H., Figliola, M. J., Dawson, M. J., Olivares, S., Zhang, L., Yang, G., Maiti, S. N., Manuri, P. R., Senyukov, V., Jena, B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064138 · Cited by 170 · see citing works
Sleeping Beauty System to Redirect T-cell Specificity for Human Applications
Maiti, S. N., Huls, H. M., Singh, H., Dawson, M. J., Figliola, M. J., Olivares, S., Rao, P., Zhao, Y., Multani, A. S., Yang, G., et al. (2013) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3182811ce9 · Cited by 82 · see citing works
Schubert, M., Schmitt, A., Sellner, L., Neuber, B., Kunz, J. B., Wuchter, P., Kunz, A. B., Gern, U., Michels, B., Hofmann, S., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-026644 · Cited by 39 · see citing works
Self-citationGenetically Modified T Cells to Target Glioblastoma
Krebs, S. S., Rodríguez-Cruz, T., DeRenzo, C. C., & Gottschalk, S. M. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00322 · Cited by 18 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Christodoulou, I., Ho, W. J., Marple, A., Ravich, J. W., Tam, A. J., Rahnama, R., Fearnow, A. D., Rietberg, C., Yanik, S. A., Solomou, E. E., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003894 · Cited by 179 · see citing works
The EBMT/EHA CAR-T Cell Handbook
Kröger, N., Gribben, J. G., Chabannon, C., Yakoub‐Agha, I., & Einsele, H. (2022) · Springer eBooks · doi:10.1007/978-3-030-94353-0 · Cited by 99 · see citing works
The Chimeric Antigen Receptor Detection Toolkit
Hu, Y., & Huang, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01770 · Cited by 70 · see citing works
Non-viral chimeric antigen receptor (CAR) T cells going viral
Balke-Want, H., Keerthi, V., Cadinanos-Garai, A., Fowler, C., Gkitsas, N., Brown, A. K., Tunuguntla, R. H., Abouelenein, M., & Feldman, S. A. (2023) · Immuno-Oncology Technology · doi:10.1016/j.iotech.2023.100375 · Cited by 72 · see citing works
Mueller, K. P., Piscopo, N. J., Forsberg, M. H., Saraspe, L. A., Das, A., Russell, B. E., Smerchansky, M. E., Cappabianca, D., Shi, L., Shankar, K., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004446 · Cited by 61 · see citing works
García-Calderón, C. B., Sierro-Martínez, B., García‐Guerrero, E., Sanoja-Flores, L., Muñoz-García, R., Ruiz-Maldonado, V., Jiménez‐León, M. R., Delgado‐Serrano, J., Molinos-Quintana, Á., Guijarro-Albaladejo, B., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1152498 · Cited by 49 · see citing works
Derigs, P., Schubert, M., Dreger, P., Schmitt, A., Yousefian, S., Haas, S. F., Röthemeier, C., Neuber, B., Hückelhoven‐Krauss, A., Brüggemann, M., et al. (2024) · Leukemia · doi:10.1038/s41375-024-02392-7 · Cited by 49 · see citing works
Self-citationSensitivity and Specificity of CD19.CAR-T Cell Detection by Flow Cytometry and PCR
Schanda, N., Sauer, T., Kunz, A. B., Hückelhoven‐Krauss, A., Neuber, B., Wang, L., Hinkelbein, M., Sedloev, D. N., He, B., Schubert, M., et al. (2021) · Cells · doi:10.3390/cells10113208 · Cited by 47 · see citing works
Self-citationKorell, F., Schubert, M., Sauer, T., Schmitt, A., Derigs, P., Weber, T. F., Schnitzler, P., Müller‐Tidow, C., Dreger, P., & Schmitt, M. W. (2021) · Cancers · doi:10.3390/cancers13071684 · Cited by 43 · see citing works
Self-citationSchubert, M., Schmitt, A., Hückelhoven‐Krauss, A., Neuber, B., Kunz, A. B., Waldhoff, P., Vonficht, D., Yousefian, S., Jopp‐Saile, L., Wang, L., et al. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01470-0 · Cited by 41 · see citing works
Self-citationEarly quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL
Blumenberg, V., Busch, G., Baumann, S., Jitschin, R., Iacoboni, G., Gallur, L., Iraola‐Truchuelo, J., Hoster, E., Winkelmann, M., Hellwig, K., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2023010364 · Cited by 40 · see citing works
Xiao, Y., Zhu, T., Chen, Z., & Huang, X. (2025) · Nature Communications · doi:10.1038/s41467-025-62506-2 · Cited by 40 · see citing works
Schubert, M., Schmitt, A., Sellner, L., Neuber, B., Kunz, J. B., Wuchter, P., Kunz, A. B., Gern, U., Michels, B., Hofmann, S., et al. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-026644 · Cited by 39 · see citing works
Self-citationGlycoprotein Targeted CAR-NK Cells for the Treatment of SARS-CoV-2 Infection
Christodoulou, I., Rahnama, R., Ravich, J. W., Seo, J., Zolov, S. N., Marple, A., Markovitz, D. M., & Bonifant, C. L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.763460 · Cited by 38 · see citing works
Retroviral gene therapy in Germany with a view on previous experience and future perspectives
Morgan, M. A., Galla, M., Grez, M., Fehse, B., & Schambach, A. (2021) · Gene Therapy · doi:10.1038/s41434-021-00237-x · Cited by 38 · see citing works
Schubert, M., Dietrich, S., Stilgenbauer, S., Schmitt, A., Pavel, P., Kunz, A. B., Bondong, A., Wegner, M., Stadtherr, P., Jung, S., et al. (2020) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2020.04.025 · Cited by 36 · see citing works
Self-citationBadbaran, A., Berger, C., Riecken, K., Kruchen, A., Geffken, M., Müller, I., Kröger, N. M., Ayuk, F. A., & Fehse, B. (2020) · Cancers · doi:10.3390/cancers12071970 · Cited by 35 · see citing works
Haderbache, R., Warda, W., Hervouet, É., Rocha, M. N. D., Trad, R., Allain, V., Nicod, C., Thieblemeont, C., Boissel, N., Varlet, P., et al. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02925-z · Cited by 35 · see citing works
Jung, S., Greiner, J., von Harsdorf, S., Popovic, P., Moll, R., Schittenhelm, J., Kandilaris, K., Daniel, V., Kunz, A. B., Schmitt, M. W., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004889 · Cited by 25 · see citing works
Self-citationCAR-T cell therapy: practical guide to routine laboratory monitoring
Selim, A. G., Minson, A. G., Blombery, P. A., Dickinson, M. J., Harrison, S. J., & Anderson, M. A. (2021) · Pathology · doi:10.1016/j.pathol.2021.02.002 · Cited by 24 · see citing works
Murphy, L. A., Marians, R. C., Miller, K. R., Brenton, M. D., Mallo, R., Kohler, M. E., Fry, T. J., & Winters, A. C. (2022) · Cytotherapy · doi:10.1016/j.jcyt.2022.09.004 · Cited by 23 · see citing works
Comparison of FACS and PCR for Detection of BCMA-CAR-T Cells
Reichman, A., Kunz, A. B., Joedicke, J. J., Höpken, U. E., Keib, A., Neuber, B., Sedloev, D. N., Wang, L., Jiang, G., Hückelhoven‐Krauss, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020903 · Cited by 21 · see citing works
Self-citationSchubert, M., Kunz, A. B., Schmitt, A., Neuber, B., Wang, L., Hückelhoven‐Krauss, A., Langner, S., Michels, B., Wick, A., Daniel, V., et al. (2020) · Cancers · doi:10.3390/cancers12102820 · Cited by 21 · see citing works
Self-citationImpact of serum‑free media on the expansion and functionality of CD19.CAR T‑cells
Eberhardt, F., Hückelhoven‐Krauss, A., Kunz, A. B., Jiang, G., Sauer, T., Reichman, A., Neuber, B., Böpple, K., Schmitt, A., Müller‐Tidow, C., et al. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5261 · Cited by 20 · see citing works
Self-citationLaurent, E., Sieber, A., Salzer, B., Wachernig, A., Seigner, J., Lehner, M., Geyeregger, R., Kratzer, B., Jaeger, U., Kunert, R., et al. (2021) · ACS Synthetic Biology · doi:10.1021/acssynbio.1c00010 · Cited by 17 · see citing works
Marton, C., Clémenceau, B., Dachy, G., Demerle, C., Derenne, S., Ferrand, C., Giverne, C., Latouche, J.-B., Lemée, L., Martinet, J., et al. (2025) · Bone Marrow Transplantation · doi:10.1038/s41409-025-02637-8 · Cited by 16 · see citing works
Point-of-Care Production of CAR-T Cells
Delgado, J., Roddie, C., & Schmitt, M. W. (2022) · Springer eBooks · doi:10.1007/978-3-030-94353-0_8 · Cited by 11 · see citing works
Self-citationSchubert, M., Berger, C., Kunz, A. B., Schmitt, A., Badbaran, A., Neuber, B., Zeschke, S., Wang, L., Riecken, K., Hückelhoven‐Krauss, A., et al. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5338 · Cited by 11 · see citing works
Self-citationNaik, S., Aplenc, R., Baumeister, S. H. C., Becilli, M., Bhagwat, A. S., Bonifant, C. L., Budde, L. E., Chien, C. D., Curran, K. J., Daniyan, A. F., et al. (2025) · Blood Advances · doi:10.1182/bloodadvances.2025017011 · Cited by 9 · see citing works
Kandell, J., Milian, S. G., Snyder, R., & Lakshmipathy, U. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.101120 · Cited by 9 · see citing works
Adaptation of lentiviral vectors for viral gene therapy and their impact on host cell biology
Kaiser, C. W., Rouchka, E. C., & Smith, M. L. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-025-07626-5 · Cited by 7 · see citing works
Gkazi, S. A., Gravett, E., Bautista, C., Bartram, J. L., Ghorashian, S., & Adams, S. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147573 · Cited by 6 · see citing works
Chen, P., Raghunandan, R., Morrow, J. S., & Katz, S. G. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.04.002 · Cited by 4 · see citing works
Tan, Q., Li, Y., Liu, C., Xu, J., Tong, J., Yu, J., Huang, Y., Hu, X., Qin, S., Xiao, F., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02488-1 · Cited by 4 · see citing works
Activation of Cell-Intrinsic Signaling in CAR-T Cells via a Chimeric IL7R Domain
Vorri, S. C., Holl, N. J., Leeming, M. G., Apostolova, P., Marple, A., Ravich, J. W., Canbaz, A. A., Rahnama, R., Choe, J., Modi, A., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0286 · Cited by 4 · see citing works
Tancos, M. A., Thomas, J. L., & Widmer, T. L. (2022) · PhytoFrontiers™ · doi:10.1094/phytofr-09-22-0094-sc · Cited by 2 · see citing works
Optimizing T cell transduction: a novel transduction device for efficient and scalable gene delivery
Lee, K.-Z., Nguyen, T. D., & Liu, D. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06836-1 · Cited by 2 · see citing works
Sun, Y., Liang, J., Li, H., Fan, Y., Peng, T., Hu, S., Gao, Y., Zhao, W., Jiang, L., Urooj, K., et al. (2026) · Analytica Chimica Acta · doi:10.1016/j.aca.2026.345421 · Cited by 2 · see citing works
Ma, J., Meyer, S., Olweus, J., Jin, C., & Yu, D. (2024) · Immuno-Oncology Technology · doi:10.1016/j.iotech.2024.101031 · Cited by 2 · see citing works
Guo, Z., He, M., Liu, N., Yang, Y., Sun, R., Wang, J., & Wang, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1521778 · Cited by 2 · see citing works
Berger, S. C., Fehse, B., & Rubio, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-94353-0_35 · Cited by 2 · see citing works
Xie, Y., Li, K., Yang, L. C., Zeng, X., Chen, Z., Ma, X., Zhang, L., Zhou, Y., Jin, L., Yang, Y., et al. (2024) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-024-03469-3 · Cited by 1 · see citing works
Li, B., Le, C., Lei, W., Zhou, Y., Zhang, Y., Wang, Y., Wang, Y., Li, X., Zheng, W., Sun, J., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08547-1 · Cited by 2 · see citing works
Current Insights of Post-Infusion CAR T Expansion and Persistence for Large B-Cell Lymphoma
Wolyncewicz, G., Wayte, R., & Abadir, E. (2025) · Cancers · doi:10.3390/cancers17193167 · Cited by 1 · see citing works
Methods to monitor in vivo expansion and efficacy of CAR-T cells in preclinical models
Alhomoud, M., Martinet, J., Sugita, M., Gomez-Arteaga, A., & Guzmán, M. L. (2022) · Methods in cell biology · doi:10.1016/bs.mcb.2021.11.004 · Cited by 1 · see citing works
Single-cell profiling of CAR-T CD19 cell phenotypes and immune system dynamics in pediatric BCP-ALLPreprint
Oszer, A., Pawlik, B., Ćwilichowska-Puślecka, N., Marschollek, P., Richert-Przygońska, M., Mielcarek‐Siedziuk, M., Crawford, J. C., Mazurek, M., Koladiya, A., Kałwak, K., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.27.645594 · Cited by 1 · see citing works
Barisic, S., Cherkasova, E. A., Nadal, R., Tian, X., Chen, L., Parrizzi, A., Reger, R. N., Scurti, G. M., Nishimura, M. I., & Childs, R. W. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101324
Schubert, M.-L., Schmitt, A., Hückelhoven‐Krauss, A., Neuber, B., Kunz, A., Waldhoff, P., Vonficht, D., Yousefian, S., Jopp‐Saile, L., Wang, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26606005
Self-citationHaderbache, R., Warda, W., Hervouet, É., Rocha, M. N. D., Trad, R., Allain, V., Nicod, C., Thieblemeont, C., Boissel, N., Varlet, P., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14821097
Yang, Y., Parikh, S., Li, C.-Y., Murphy, L. A., Patel, K., Ayaz, Q., Mohiuddin, M., Elliott, J. T., He, H., He, Z., et al. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201738
Hsu, F., Weng, Y., Yueh, P., Chiang, C.-S., Chiang, I., Liu, Y.-C., Shyu, W., & Jeng, L. (2026) · Research Square · doi:10.21203/rs.3.rs-9490147/v1
Vidal-Manrique, M., Hooijmaijers, L., Teders, J. A. J., Saf, E., Klarenbeek, K., Hagemans, I. M., Cuenca‐Escalona, J., Cambi, A., de Vries, I. J., de Jonge, P. K. J. D., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1792303
Li, W. (2026) · Springer eBooks · doi:10.1007/978-3-032-26557-9_16
Sato, Y., Matsushima, S. K., Shimada, Y., & Kobayashi, H. (2026) · Molecular Therapy Advances · doi:10.1016/j.omta.2026.201836
- Authors
- Kunz, A., Gern, U., Schmitt, A., Neuber, B., Wang, L., Hückelhoven-Krauss, A., Michels, B., Hofmann, S., Müller-Tidow, C., Dreger, P., Schmitt, M., & Schubert, M.-L.
- Affiliations
- University Hospital Heidelberg (DE)
- German Cancer Research Center (DE)
- Corresponding author
- Kunz, Alexander
- Venue
- Molecular Therapy - Methods & Clinical Development
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 17
- Pages
- 448-454
- ISSN
- 2329-0501 (ISSN-L)
- PMC
- PMC7078460
- OpenAlex
- W3008785730
- Cited by
- 54
- References
- 20
- Citations by year
- 2026: 7 · 2025: 9 · 2024: 7 · 2023: 6 · 2022: 10 · 2021: 10 · 2020: 4 · 2019: 1
- FWCI
- 2.71
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecular Therapy — Methods & Clinical Development (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Baylor College of Medicine
- Anacostia Community Museum
- Topics
- Health Sciences › Medicine › Oncology › CAR-T cell therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Keywords
- chimeric antigen receptor T cells, vector copy number, single-copy gene, duplex qPCR, good manufacturing practices, vector safety, assay validation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
